Our analysis

Eleonora Nicolò: Our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age

Eleonora Nicolò, Research Fellow at Weill Cornell Medicine, shared a post on X:

“Just out in EJC (European Journal of Cancer) our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age.

Age, per se, should not represent a barrier when considering early-phase clinical trials as a treatment option.”

Visit the article website.
Source: Eleonora Nicolò/X

Eleonora Nicolò: Our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age

Ambra Carnevale Schianca Angela Esposito Antonio Marra cancer Carmen Belli carmen criscitiello clinical trials Dario Trapani efficacy of new drugs EJC Eleonora Nicolò Emanuela Ferraro European Journal of Cancer Federica Giugliano Giuseppe Curigliano Ida Minchella Irene Caramella Jacopo Uliano Laura Boldrini Marzia Adelia Locatelli Massimo Cristofanilli OncoDaily Oncology Oriana D’Ecclesiis Paola Zagami Paolo Tarantino safety of new drugs Sara Gandini Stefania Morganti Weill Cornell Medicine